BECA, J.; MAJEED, H.; CHAN, K. K.; HOTTE, S. J.; LOBLAW, A.; HOCH, J. S. Cost-effectiveness of docetaxel in high-volume hormone-sensitive metastatic prostate cancer. Canadian Urological Association Journal, v. 13, n. 12, p. 396-403, 26 Apr. 2019.